Synthon IP, Inc. v. Pfizer, Inc.

Federal Circuit

Synthon IP, Inc. v. Pfizer, Inc.

281 F. App'x 995

Court of Appeals for the Federal Circuit·Decided June 17, 2008·No. No. 2007-1344·Published

Opinion

PER CURIAM.

The court, having considered the submissions and oral arguments of the parties, and having considered the record before and judgment of the United States District Court for the Eastern District of Virginia, holds that the findings of inequitable conduct and exceptional case, and the award of attorney fees are affirmed. Under these circumstances, we need not reach the issues of infringement and validity-

Free access — add to your briefcase to read the full text and ask questions with AI

PER CURIAM.

The court, having considered the submissions and oral arguments of the parties, and having considered the record before and judgment of the United States District Court for the Eastern District of Virginia, holds that the findings of inequitable conduct and exceptional case, and the award of attorney fees are affirmed. Under these circumstances, we need not reach the issues of infringement and validity-

Synthon IP, Inc. v. Pfizer, Inc., 281 F. App'x 995 (Fed. Cir. 2008).

Pincite

281 F. App'x 995 (Synthon IP, Inc. v. Pfizer, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.